Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
2006;27(7):736 to 749
Are glutathione tablets effective
ARA-290 received FDA Orphan Drug Designation for this indication TRPV1-mediated pain models ARA-290 demonstrated specific inhibition of TRPV1 channel activity, relieving capsaicin-induced mechanical hypersensitivity in pre-clinical nociceptor models Complex Regional Pain Syndrome (CRPS) investigational studies have examined ARA-290 in CRPS models due to its dual anti-inflammatory and nociceptor-targeting mechanism Chronic neuropathic pain multiple studies confirm ARA-290 reduces neuroinflammation in the spinal cord by suppressing TNF-, IL-1, and other pro-inflammatory cytokines that maintain chronic pain states Neuroprotection and CNS Research: Cerebral ischaemia/stroke models Wang et al
Enhanced fat oxidation and improved energy availability
Hormonal Changes Hormonal fluctuations may contribute to melasma, a condition characterised by symmetrical brown or greyish patches, commonly affecting the cheeks, forehead, or upper lip
US$ 23.49
US$ 22.58
US$ 28.84
US$ 26.78
US$ 22.27
US$ 25.91
US$ 23.39
US$ 22.34
US$ 27.68
US$ 21.46
US$ 28.42
US$ 29.66
US$ 27.54
US$ 28.15
US$ 22.12
US$ 27.41
